Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

RETACRIT™ Contraindications (epoetin alfa-epbx)

4 CONTRAINDICATIONS

RETACRIT is contraindicated in patients with:

Uncontrolled hypertension [see Warnings and Precautions (5.3)].
Pure red cell aplasia (PRCA) that begins after treatment with RETACRIT or other erythropoietin protein drugs [see Warnings and Precautions (5.6)].
Serious allergic reactions to RETACRIT or other epoetin alfa products [see Warnings and Precautions (5.7)].

RETACRIT from multiple-dose vials contains benzyl alcohol and is contraindicated in:

Neonates, infants, pregnant women, and lactating women [see Warnings and Precautions (5.9), Use in Specific Populations (8.1,8.2, and 8.4)]
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event